- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvanted influenza vaccines
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 8, Issue 1, Pages 59-66
Publisher
Informa UK Limited
Online
2012-02-02
DOI
10.4161/hv.8.1.18011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
- (2012) Laurent Coudeville et al. BMC Medical Research Methodology
- A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses
- (2011) Jiri Beran et al. CLINICAL THERAPEUTICS
- Present and future of influenza prevention in pediatrics
- (2011) Nicola Principi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age
- (2011) Adriano Arguedas et al. Human vaccines & immunotherapeutics
- Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03A-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial
- (2011) Stéphane Heijmans et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza A/H1N1 MF59-Adjuvanted Vaccine in Preterm and Term Children Aged 6 to 23 Months
- (2011) S. Esposito et al. PEDIATRICS
- Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles
- (2011) Christian Savard et al. PLoS One
- Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice
- (2011) Ge Liu et al. PLoS One
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination
- (2011) Elisabetta Parretta et al. VACCINE
- Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
- (2011) David N. Taylor et al. VACCINE
- Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents
- (2011) J. Garcia-Sicilia et al. VACCINE
- Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases
- (2011) Ori Elkayam et al. ARTHRITIS CARE & RESEARCH
- Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients
- (2010) O. Manuel et al. CLINICAL INFECTIOUS DISEASES
- The virosomal adjuvanted influenza vaccine
- (2010) Selma Calcagnile et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
- (2010) Paolo Durando et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients
- (2010) S. Esposito et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
- (2010) T. Vesikari et al. PEDIATRICS
- Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine
- (2010) Orli Even-Or et al. VACCINE
- The role of adjuvants in vaccines for seasonal and pandemic influenza
- (2010) Lorena E. Brown VACCINE
- Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major
- (2010) Susanna Esposito et al. VACCINE
- Unmet needs in modern vaccinology
- (2010) Geert Leroux-Roels VACCINE
- Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months
- (2010) Alfonso Carmona et al. VACCINE
- Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN
- (2010) Amirul Islam Mallick et al. VACCINE
- On the relationship between mean antibody level, seroprotection and clinical protection from influenza
- (2009) Jozef J.P. Nauta et al. BIOLOGICALS
- Vaccination, squalene and anti-squalene antibodies: Facts or fiction?
- (2009) Giuseppe Lippi et al. European Journal of Internal Medicine
- Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data
- (2009) Geert Leroux-Roels EXPERT OPINION ON BIOLOGICAL THERAPY
- Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant
- (2009) Eugene Maraskovsky et al. IMMUNOLOGY AND CELL BIOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
- (2009) Tristan W. Clark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Single dose intranasal immunization with ISCOMATRIX™ vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract
- (2009) Megan T. Sanders et al. VACCINE
- Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
- (2009) Daniel Wai-Sing Chu et al. VACCINE
- MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
- (2009) T. Vesikari et al. VACCINE
- Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
- (2009) Tino F. Schwarz et al. VACCINE
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- The Global State of Influenza in Children
- (2008) Susanna Esposito et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs
- (2008) Langzhou Song et al. PLoS One
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
- (2008) Jérôme Denis et al. VACCINE
- Safety of MF59™ adjuvant
- (2008) Viola Schultze et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search